Recherche avancée
Affichage des résultats 3481 à 3500 sur 8471 au total
-
Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysis
Catherine Cornu, C. Dufays, Ségolène Gaillard, François Gueyffier, M. Redonnet, Laurent Sebbag, A. Roussoulieres, C. A. Gleissner, J. Groetzner, H. B. Lehmkuhl, L. Potena, L. Gullestad, M. Cantarovich, P. Boissonnat
-
Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies: Systematic Review and Meta-analysis
M. Thulliez, D. Angoulvant, M. L. Le Lez, Annie-Pierre Jonville-Bera, P. J. Pisella, François Gueyffier, T. Bejan-Angoulvant
-
Guidelines for Managing High Blood Pressure
Dk. Cundiff, François Gueyffier, Jm. Wright
-
Comparison of an effect-model-law-based method versus traditional clinical practice guidelines for optimal treatment decision-making: application to statin treatment in the French population
R. Kahoul, François Gueyffier, E. Amsallem, M. Haugh, I. Marchant, F. H. Boissel, Jp. Boissel
-
Multivariate meta-analysis using individual participant data
R. D. Riley, M. J. Price, D. Jackson, M. Wardle, François Gueyffier, J. Wang, J. A. Staessen, I. R. White
-
Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?
R. Boussageon, François Gueyffier, Catherine Cornu
-
Improving risk prediction performance for a better guidelines application
I. Marchant, T. Bejan-Angoulvant, Hh. Le, François Gueyffier
-
Études pharmaco-épidémiologiques : quels niveaux de preuve et comment les atteindre ?
M. Lapeyre-Mestre, C. Sapède, N. Moore, P. Bilbault, P. Blin, D. Chopy, D. Evans, François Gueyffier, L. Lacoin, M. Malbezin, J. Micallef, D. Morlet-Vigier, S. Muller, E. Oger, Y. Plétan, Gérard Pons, P. Verpillat, C. Vigneau
-
Correspondance à propos de l\textquoterightarticle \guillemotleft Objectifs glycémiques dans la prise en charge du diabète de type 2 \guillemotright
R. Boussageon, François Gueyffier, C. Cornu
-
Clinically Relevant Efficacy of Insulin Therapy in Patients with Type 2 Diabetes
R. Boussageon, J. M. Gamble, François Gueyffier, C. Cornu
-
Is there excess mortality in women screened with mammography: a meta-analysis of non-breast cancer mortality
Sylvie Erpeldinger, Laure Fayolle, Rémy Boussageon, Marie Flori, Xavier Lainé, Moreau Alain, François Gueyffier
-
Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials
M. Al-Gobari, C. El Khatib, F. Pillon, François Gueyffier
-
Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.
Esber S Saba, Lucie Gueyffier, Marie-Laure Dichtel-Danjoy, Bruno Pozzetto, Thomas Bourlet, François Gueyffier, Yahia Mekki, Hans Pottel, Ester C Sabino, Philippe Vanhems, Maan A Zrein
-
Revising the ECRIN standard requirements for information technology and data management in clinical trials.
Christian Ohmann, Steve Canham, Catherine Cornu, Jochen Dress, François Gueyffier, Wolfgang Kuchinke, Enrico Nicolis, Michael Wittenberg
-
Pharmacoepidemiology studies: what levels of evidence and how can they be reached?
Maryse Lapeyre-Mestre, Claudine Sapède, Nicholas Moore, Pascal Bilbault, Patrick Blin, Damien Chopy, David Evans, François Gueyffier, Laure Lacoin, Muriel Malbezin, Joëlle Micallef, Dana Morlet-Vigier, Sophie Muller, Emmanuel Oger, Yannick Plétan, Gérard Pons, Patrice Verpillat, Caroline Vigneau
-
Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties
D. Dobre, J. S. Borer, K. Fox, K. Swedberg, K. F. Adams, J. G. Cleland, A. Cohen-Solal, M. Gheorghiade, François Gueyffier, C. M. O'Connor, M. Fiuzat, A. Patak, I. L. Pina, G. Rosano, H. N. Sabbah, L. Tavazzi, F. Zannad
-
Apport de la modélisation et des populations virtuelles pour transposer les résultats des essais cliniques à la vie réelle et éclairer la décision publique
François Gueyffier, C. B. Strang, G. Berdeaux, L. R. França, P. Blin, J. Benichou, J. Massol
-
Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) influenza virus infections
V. Escuret, C. Cornu, F. Boutitie, V. Ernouf, A. Mosnier, M. Bouscambert-Duchamp, S. Gaillard, X. Duval, T. Blanchon, C. Leport, François Gueyffier, S. van Der Werf, B. Lina
-
Farnesoid X Receptor Targeting for Hepatitis C: Study Protocol for a Proof-of-concept Trial
C. Scholtes, P. Andre, C. Trepo, C. Cornu, Laurent Remontet, René Ecochard, Théodora Bejan-Angoulvant, François Gueyffier
-
Traitement anti-hypertenseur et tabac
R. Boussageon, G. Grand, François Gueyffier